Jazz Pharmaceuticals plc total revenue, net income and dynamics of changes in US dollar today
Net revenue of Jazz Pharmaceuticals plc on 31/03/2021 amounted to 607 581 000 $. The dynamics of Jazz Pharmaceuticals plc net revenue fell by -57 936 000 $ compared to the previous report. The dynamics of net income of Jazz Pharmaceuticals plc has changed by -11 582 000 $ in recent years. The financial graph of Jazz Pharmaceuticals plc displays the online status: net income, net revenue, total assets. The financial report schedule from 30/06/2017 to 31/03/2021 is available online. Information on Jazz Pharmaceuticals plc net income on the chart on this page is drawn in blue bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
607 581 000 $
+19.56 % ↑
121 832 000 $
+42.99 % ↑
31/12/2020
665 517 000 $
+39.68 % ↑
133 414 000 $
-16.339 % ↓
30/09/2020
600 888 000 $
+11.75 % ↑
148 234 000 $
+44.94 % ↑
30/06/2020
562 436 000 $
+5.3 % ↑
114 801 000 $
-56.166 % ↓
30/09/2019
537 702 000 $
-
102 276 000 $
-
30/06/2019
534 133 000 $
-
261 898 000 $
-
31/03/2019
508 186 000 $
-
85 201 000 $
-
31/12/2018
476 457 000 $
-
159 470 000 $
-
30/09/2018
469 373 000 $
-
149 316 000 $
-
30/06/2018
500 479 000 $
-
92 321 000 $
-
31/03/2018
444 613 000 $
-
45 991 000 $
-
31/12/2017
436 399 000 $
-
232 207 000 $
-
30/09/2017
411 855 000 $
-
63 526 000 $
-
30/06/2017
394 386 000 $
-
105 604 000 $
-
Show:
to
Jazz Pharmaceuticals plc financial report charts
Dates of Jazz Pharmaceuticals plc finance reports: 30/06/2017, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest financial report of Jazz Pharmaceuticals plc is available online for such a date - 31/03/2021. Gross profit Jazz Pharmaceuticals plc is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Jazz Pharmaceuticals plc is 567 392 000 $
Jazz Pharmaceuticals plc quarterly report dates
Cost of revenue Jazz Pharmaceuticals plc is the total cost of producing and distributing of products and services of a company. Cost of revenue Jazz Pharmaceuticals plc is 40 189 000 $ Total revenue Jazz Pharmaceuticals plc refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Jazz Pharmaceuticals plc is 607 581 000 $ Operating income Jazz Pharmaceuticals plc is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Jazz Pharmaceuticals plc is 162 119 000 $
Net income Jazz Pharmaceuticals plc is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Jazz Pharmaceuticals plc is 121 832 000 $ Current assets Jazz Pharmaceuticals plc is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Jazz Pharmaceuticals plc is 3 166 896 000 $ Total assets Jazz Pharmaceuticals plc refers to the total amount of assets owned by a person or entity. Total assets Jazz Pharmaceuticals plc is 6 756 470 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
567 392 000 $
615 360 000 $
558 793 000 $
534 428 000 $
506 302 000 $
506 457 000 $
474 680 000 $
450 120 000 $
442 799 000 $
465 765 000 $
410 694 000 $
411 151 000 $
380 652 000 $
365 714 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
40 189 000 $
50 157 000 $
42 095 000 $
28 008 000 $
31 400 000 $
27 676 000 $
33 506 000 $
26 337 000 $
26 574 000 $
34 714 000 $
33 919 000 $
25 248 000 $
31 203 000 $
28 672 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
607 581 000 $
665 517 000 $
600 888 000 $
562 436 000 $
537 702 000 $
534 133 000 $
508 186 000 $
476 457 000 $
469 373 000 $
500 479 000 $
444 613 000 $
436 399 000 $
411 855 000 $
394 386 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
537 702 000 $
534 133 000 $
508 186 000 $
476 457 000 $
469 373 000 $
500 479 000 $
440 847 000 $
430 095 000 $
407 971 000 $
389 655 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
162 119 000 $
209 414 000 $
206 207 000 $
201 126 000 $
184 878 000 $
206 483 000 $
189 743 000 $
185 455 000 $
188 777 000 $
196 095 000 $
87 807 000 $
141 205 000 $
86 454 000 $
165 043 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
121 832 000 $
133 414 000 $
148 234 000 $
114 801 000 $
102 276 000 $
261 898 000 $
85 201 000 $
159 470 000 $
149 316 000 $
92 321 000 $
45 991 000 $
232 207 000 $
63 526 000 $
105 604 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
69 651 000 $
91 699 000 $
78 647 000 $
78 922 000 $
79 855 000 $
62 384 000 $
60 105 000 $
52 657 000 $
51 160 000 $
56 132 000 $
62 667 000 $
73 995 000 $
122 362 000 $
42 157 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
445 462 000 $
456 103 000 $
394 681 000 $
361 310 000 $
352 824 000 $
327 650 000 $
318 443 000 $
291 002 000 $
280 596 000 $
304 384 000 $
322 887 000 $
269 946 000 $
294 198 000 $
200 671 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
3 166 896 000 $
2 839 568 000 $
2 555 573 000 $
2 302 346 000 $
1 520 556 000 $
1 370 066 000 $
1 305 617 000 $
1 234 005 000 $
1 464 389 000 $
1 306 931 000 $
1 126 321 000 $
968 277 000 $
830 944 000 $
662 504 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
6 756 470 000 $
6 535 901 000 $
6 291 958 000 $
6 066 501 000 $
5 527 850 000 $
5 488 661 000 $
5 280 235 000 $
5 203 491 000 $
5 485 788 000 $
5 348 967 000 $
5 287 128 000 $
5 123 672 000 $
4 999 024 000 $
4 804 024 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
2 097 533 000 $
1 057 769 000 $
741 942 000 $
786 082 000 $
795 175 000 $
637 739 000 $
547 466 000 $
309 622 000 $
499 018 000 $
485 081 000 $
453 169 000 $
386 035 000 $
252 615 000 $
239 213 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
390 439 000 $
369 493 000 $
413 999 000 $
345 487 000 $
341 287 000 $
347 950 000 $
45 117 000 $
40 605 000 $
36 094 000 $
36 094 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
708 169 000 $
601 035 000 $
452 615 000 $
319 213 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
2 473 445 000 $
2 505 227 000 $
2 549 788 000 $
2 446 069 000 $
2 458 471 000 $
2 479 215 000 $
1 582 161 000 $
1 581 038 000 $
1 579 913 000 $
1 671 894 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
44.75 %
45.64 %
48.29 %
47.01 %
44.82 %
46.35 %
29.92 %
30.86 %
31.60 %
34.80 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
3 797 689 000 $
3 659 745 000 $
3 377 201 000 $
3 141 805 000 $
3 054 405 000 $
2 983 434 000 $
2 730 447 000 $
2 757 422 000 $
3 027 317 000 $
2 869 752 000 $
2 786 571 000 $
2 713 097 000 $
2 469 297 000 $
2 201 032 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
337 503 000 $
148 847 000 $
202 253 000 $
224 346 000 $
220 575 000 $
191 624 000 $
162 359 000 $
204 559 000 $
188 897 000 $
135 091 000 $
Last revenue report of Jazz Pharmaceuticals plc was 31/03/2021. According to last financial report total revenue in Jazz Pharmaceuticals plc was 607 581 000 US dollar and changed by +19.56% since last year. Net income in Jazz Pharmaceuticals plc was 121 832 000 $ in last quartal, net income changes to +42.99%.
Current cash Jazz Pharmaceuticals plc - the sum of all of the cash a company has on the date of report. Current cash Jazz Pharmaceuticals plc is 2 097 533 000 $
Jazz Pharmaceuticals plc stocks data
JAZZ stock price
Jazz Pharmaceuticals plc stock price today, JAZZ stock quote.
